INmune Bio, Inc. (INMB) Q2 2025 Earnings Call Transcript

2025-08-08 15:23:34 ET

INmune Bio, Inc. (INMB)

Q2 2025 Earnings Conference Call

August 07, 2025, 04:30 PM ET

Company Participants

Christopher Barnum - Corporate Participant

Daniel Carlson - Corporate Participant

David J. Moss - CFO, Treasurer & Secretary

Mark William Lowdell - Chief Scientific Officer & Chief Manufacturing Officer

Raymond Joseph Tesi - Co-Founder, President, CEO, Chief Medical Officer & Chairman

Conference Call Participants

Boris Tolkachev - Freedom Broker, Research Division

Denis Reznik - Raymond James Ltd., Research Division

James Francis Molloy - Alliance Global Partners, Research Division

Jenny Shen - BTIG, LLC, Research Division

Presentation

Operator

Greetings, and welcome to the INmune Bio Second Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call....

Read the full article on Seeking Alpha

For further details see: